Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators
AssigneeDana-Farber Cancer Institute, Inc.
InventorsMark Bittinger, Jessie M. English, Kwok-Kin Wong, Sima Zacharek
Life of this patent
Estimating the term…
Abstract
The present invention is based, in part, on the identification, of novel mitochondrial iron-sulfur (Fe—S) cluster biosynthesis pathway biomarkers and modulators, and methods of use thereof, for identifying, assessing, preventing, and treating cancer.
Claims1
A method of inhibiting hyperproliferative growth of a cancer cell or cells, the method comprising contacting the cancer cell or cells with an shRNA or an siRNA targeting NFS1, thereby inhibiting hyperproliferative growth of the cancer cell or cells, wherein the step of contacting occurs ex vivo or in vitro, optionally wherein
- i) the shRNA or siRNA is administered in a pharmaceutically acceptable formulation;
- ii) the NFS1 is human NFS1;
- and/or
- iii) the cancer is selected from the group consisting of paragangliomas, colorectal cancer, cervical cancer, lung adenocarcinoma, ovarian cancer, and myeloid cancer within a hypoxic tumor microenvironment.
Dependencies are inferred from the claim text.